{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:34:47Z","timestamp":1791387287320,"version":"4.3.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of KwaZulu-Natal, Talent Excellence Scholarship"},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["96151"],"award-info":[{"award-number":["96151"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["TTK160517165310"],"award-info":[{"award-number":["TTK160517165310"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scare Skills Postdoctoral Fellowship","award":["132714"],"award-info":[{"award-number":["132714"]}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RCA13101656388"],"award-info":[{"award-number":["RCA13101656388"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 96354"],"award-info":[{"award-number":["UID 96354"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2017SF-1960"],"award-info":[{"award-number":["TMA2017SF-1960"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["BMDF,INV-018075"],"award-info":[{"award-number":["BMDF,INV-018075"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thuthuka Research Grant","award":["TTK160510164586"],"award-info":[{"award-number":["TTK160510164586"]}]},{"name":"Southern African Fogarty AITRP Programme","award":["D43TW00231"],"award-info":[{"award-number":["D43TW00231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaginal microbiota have been shown to be a modifier of protection offered by topical tenofovir in preventing HIV infection in women, an effect not observed with oral tenofovir-based pre-exposure prophylaxis (PrEP). It remains unclear whether PrEP can influence the vaginal microbiota composition. This study investigated the impact of daily oral tenofovir disoproxil fumarate in combination with emtricitabine for PrEP on the vaginal microbiota in South African women. At baseline, <jats:italic>Lactobacillus iners<\/jats:italic> or <jats:italic>Gardnerella vaginalis<\/jats:italic> dominant vaginal communities were observed in the majority of participants. In cross sectional analysis, vaginal microbiota were not affected by the initiation and use of PrEP. Longitudinal analysis revealed that <jats:italic>Lactobacillus crispatus<\/jats:italic>-dominant \u201ccervicotypes 1 (CT1)\u201d communities had high probability of remaining stable in PrEP group, but had a higher probability of transitioning to <jats:italic>L. iners<\/jats:italic>-dominant CT2 communities in non-PrEP group. <jats:italic>L. iners<\/jats:italic>-dominant communities were more likely to transition to communities associated with bacterial vaginosis (BV), irrespective of PrEP or antibiotic use. As expected, BV-linked CTs had a higher probability of transitioning to <jats:italic>L. iners<\/jats:italic> than <jats:italic>L. crispatus<\/jats:italic> dominant CTs and this shift was not associated with PrEP use.<\/jats:p>","DOI":"10.1038\/s41598-022-20486-z","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:03:16Z","timestamp":1664366596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women"],"prefix":"10.1038","volume":"12","author":[{"given":"Noluthando","family":"Mazibuko-Motau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Sobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Ahmed","family":"Elsherbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"San","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andile","family":"Mtshali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gugulethu","family":"Mzobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lungelo","family":"Ntuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quarraisha","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derseree","family":"Archary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinaye","family":"Ngcapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"20486_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M. et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N. Engl. J. Med. 367, 399\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1108524 (2012).","journal-title":"N. Engl. J. Med."},{"key":"20486_CR2","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587\u20132599. https:\/\/doi.org\/10.1056\/NEJMoa1011205 (2010).","journal-title":"N. Engl. J. Med."},{"key":"20486_CR3","unstructured":"McCormack, S., Dunn, D. & On behalf of the PROUD Study Group. in Conference on Retroviruses and Opportunistic Infections (CROI), 23\u201326 February (Seattle, Washington, 2015)."},{"key":"20486_CR4","unstructured":"Molina, J.-M. et al. in Conference on Retroviruses and Opportunistic Infections."},{"key":"20486_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C. et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N. Engl. J. Med. 367, 423\u2013434 (2012).","journal-title":"N. Engl. J. Med."},{"key":"20486_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L. et al. Preexposure prophylaxis for HIV infection among African women. N. Engl. J. Med. 367, 411\u2013422 (2012).","journal-title":"N. Engl. J. Med."},{"key":"20486_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya, K. et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet 381, 2083\u20132090 (2013).","journal-title":"The Lancet"},{"key":"20486_CR8","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim, Q. et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168\u20131174 (2010).","journal-title":"Science"},{"key":"20486_CR9","unstructured":"Rees H. et al. in Conference on Retroviruses and Opportunistic Infections (CROI) (Seattle, Washington, 2015)."},{"key":"20486_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.aai9383","volume":"356","author":"NR Klatt","year":"2017","unstructured":"Klatt, N. R. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356, 938\u2013945. https:\/\/doi.org\/10.1126\/science.aai9383 (2017).","journal-title":"Science"},{"key":"20486_CR11","unstructured":"Hillier, S. L. et al. in Conference on Retroviruses and Opportunistic Infections."},{"key":"20486_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30110-8","author":"R Heffron","year":"2017","unstructured":"Heffron, R. et al. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled partners PrEP study. Lancet HIV https:\/\/doi.org\/10.1016\/S2352-3018(17)30110-8 (2017).","journal-title":"Lancet HIV"},{"key":"20486_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25957","volume":"25","author":"LE Mansoor","year":"2022","unstructured":"Mansoor, L. E. et al. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa. J. Int. AIDS Soc. 25, e25957. https:\/\/doi.org\/10.1002\/jia2.25957 (2022).","journal-title":"J. Int. AIDS Soc."},{"key":"20486_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","volume":"42","author":"MN Anahtar","year":"2015","unstructured":"Anahtar, M. N. et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 42, 965\u2013976. https:\/\/doi.org\/10.1016\/j.immuni.2015.04.019 (2015).","journal-title":"Immunity"},{"key":"20486_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"20486_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ismej.2011.139","volume":"6","author":"D McDonald","year":"2012","unstructured":"McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610\u2013618. https:\/\/doi.org\/10.1038\/ismej.2011.139 (2012).","journal-title":"ISME J."},{"key":"20486_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217. https:\/\/doi.org\/10.1371\/journal.pone.0061217 (2013).","journal-title":"PLoS ONE"},{"key":"20486_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","volume":"46","author":"C Gosmann","year":"2017","unstructured":"Gosmann, C. et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 46, 29\u201337. https:\/\/doi.org\/10.1016\/j.immuni.2016.12.013 (2017).","journal-title":"Immunity"},{"key":"20486_CR19","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (2015)."},{"key":"20486_CR20","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1099\/mic.0.081034-0","volume":"160","author":"JM Fettweis","year":"2014","unstructured":"Fettweis, J. M. et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 160, 2272\u20132282. https:\/\/doi.org\/10.1099\/mic.0.081034-0 (2014).","journal-title":"Microbiology"},{"issue":"Suppl 1","key":"20486_CR21","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl 1), 4680\u20134687. https:\/\/doi.org\/10.1073\/pnas.1002611107 (2011).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"20486_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00410-17","author":"K Lennard","year":"2018","unstructured":"Lennard, K. et al. Microbial composition predicts genital tract inflammation and persistent bacterial vaginosis in South African adolescent females. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00410-17 (2018).","journal-title":"Infect. Immun."},{"key":"20486_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730986","author":"A Mtshali","year":"2021","unstructured":"Mtshali, A. et al. Temporal changes in vaginal microbiota and genital tract cytokines among South African women treated for bacterial vaginosis. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.730986 (2021).","journal-title":"Front. Immunol."},{"key":"20486_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fcimb.2020.00350","volume":"10","author":"L Riganelli","year":"2020","unstructured":"Riganelli, L. et al. Structural variations of vaginal and endometrial microbiota: Hints on female infertility. Front. Cell Infect. Microbiol. 10, 350. https:\/\/doi.org\/10.3389\/fcimb.2020.00350 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"20486_CR25","doi-asserted-by":"publisher","first-page":"132ra152","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra152-132ra152 (2012).","journal-title":"Sci. Transl. Med."},{"key":"20486_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.chom.2018.01.013","volume":"23","author":"MN Anahtar","year":"2018","unstructured":"Anahtar, M. N., Gootenberg, D. B., Mitchell, C. M. & Kwon, D. S. Cervicovaginal microbiota and reproductive health: The virtue of simplicity. Cell Host Microbe 23, 159\u2013168. https:\/\/doi.org\/10.1016\/j.chom.2018.01.013 (2018).","journal-title":"Cell Host Microbe"},{"key":"20486_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40168-021-01096-9","volume":"9","author":"A Munoz","year":"2021","unstructured":"Munoz, A. et al. Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health. Microbiome 9, 163. https:\/\/doi.org\/10.1186\/s40168-021-01096-9 (2021).","journal-title":"Microbiome"},{"issue":"Suppl 1","key":"20486_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiw121","volume":"214","author":"CA Muzny","year":"2016","unstructured":"Muzny, C. A. & Schwebke, J. R. Pathogenesis of bacterial vaginosis: Discussion of current hypotheses. J. Infect. Dis. 214(Suppl 1), S1-5. https:\/\/doi.org\/10.1093\/infdis\/jiw121 (2016).","journal-title":"J. Infect. Dis."},{"key":"20486_CR29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/cid\/ciy762","volume":"68","author":"V Joag","year":"2019","unstructured":"Joag, V. et al. Impact of standard bacterial vaginosis treatment on the genital microbiota, immune milieu, and ex vivo human immunodeficiency virus susceptibility. Clin. Infect. Dis. 68, 1675\u20131683. https:\/\/doi.org\/10.1093\/cid\/ciy762 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"20486_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.08.008","author":"MC Verwijs","year":"2019","unstructured":"Verwijs, M. C., Agaba, S. K., Darby, A. C. & van de Wijgert, J. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2019.08.008 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20486_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2049-2618-1-29","volume":"1","author":"J Ravel","year":"2013","unstructured":"Ravel, J. et al. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1, 29. https:\/\/doi.org\/10.1186\/2049-2618-1-29 (2013).","journal-title":"Microbiome"},{"key":"20486_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236036","volume":"15","author":"P Ahrens","year":"2020","unstructured":"Ahrens, P. et al. Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis. PLoS ONE 15, e0236036. https:\/\/doi.org\/10.1371\/journal.pone.0236036 (2020).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20486-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:30:07Z","timestamp":1664368207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20486-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20486-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16187"}}